V1 sact_drug_detail
6,385,827 rows · 11 columns
| MERGED_DRUG_DETAIL_ID | MERGED_CYCLE_ID | ORG_CODE_OF_DRUG_PROVIDER | ACTUAL_DOSE_PER_ADMINISTRATION | OPCS_DELIVERY_CODE | ADMINISTRATION_ROUTE | ADMINISTRATION_DATE | DRUG_GROUP | MERGED_PATIENT_ID | MERGED_TUMOUR_ID | MERGED_REGIMEN_ID |
|---|---|---|---|---|---|---|---|---|---|---|
| 16625595 | 330006105 | ERS12 | 10 | X721 | 1 | 2016-03-31 | NOT CHEMO | 330021306 | 330010119 | 330006105 |
| 16625596 | 330006109 | ECL01 | 8 | X721 | 1 | 2016-07-04 | NOT CHEMO | 330021497 | 330002901 | 330006109 |
| 16625597 | 330006110 | EGENG | 500 | X721 | 1 | null | NOT CHEMO | 330021531 | 330007560 | 330006110 |
| 16625598 | 330006110 | ECL02 | 580 | X721 | 1 | null | TRIAL | 330021531 | 330007560 | 330006110 |
| 16625599 | 330006111 | ECL02 | 500 | X721 | 1 | 2013-11-28 | NOT CHEMO | 330021539 | 330002902 | 330006111 |
| 16625600 | 330006111 | ED301 | 180 | X721 | 1 | 2013-11-28 | IFOSFAMIDE | 330021539 | 330002902 | 330006111 |
| 16625601 | 330006111 | ECL01 | 4240 | X729 | 1 | 2013-11-28 | CYCLOPHOSPHAMIDE | 330021539 | 330002902 | 330006111 |
| 16625602 | 330006111 | EGU08 | 0 | X724 | 1 | 2013-11-28 | PEMBROLIZUMAB | 330021539 | 330002902 | 330006111 |
| 16625603 | 330006112 | EJN | 8 | null | 2 | 2017-12-15 | STEROID | 330021565 | 330002903 | 330006112 |
| 16625604 | 330006112 | ETG | 2960 | null | 1 | 2017-12-16 | METHOTREXATE | 330021565 | 330002903 | 330006112 |
| 16625605 | 330006112 | E0N03 | 2850 | X722 | 1 | 2017-12-16 | NOT MATCHED | 330021565 | 330002903 | 330006112 |
| 16625606 | 330006113 | EWR01 | 8 | null | 2 | 2017-02-26 | NOT CHEMO | 330021705 | 330007561 | 330006113 |
| 16625607 | 330006113 | EPH | 100 | X724 | 1 | 2017-02-27 | MESNA | 330021705 | 330007561 | 330006113 |
| 16625608 | 330006113 | EEI00 | 1800 | X724 | 1 | 2017-02-27 | NOT CHEMO | 330021705 | 330007561 | 330006113 |
| 16625609 | 330006113 | EPH | 0.75 | null | 1 | 2017-02-28 | RITUXIMAB | 330021705 | 330007561 | 330006113 |
| 16625610 | 330006115 | EN201 | 0 | X721 | 2 | 2015-07-07 | NOT CHEMO | 330021733 | 330002904 | 330006115 |
| 16625611 | 330006118 | EKA | 8 | null | 1 | 2017-11-04 | NOT CHEMO | 330021733 | 330002904 | 330006118 |
| 16625612 | 330006119 | ETD02 | 20 | null | 1 | 2014-03-02 | NOT CHEMO | 330022480 | 330002905 | 330006119 |
| 16625613 | 330006119 | EEI00 | 1960 | null | 1 | 2014-03-02 | AZACITIDINE | 330022480 | 330002905 | 330006119 |
| 16625614 | 330006119 | EEI00 | 580 | X724 | 1 | 2014-03-03 | CYTARABINE | 330022480 | 330002905 | 330006119 |
| 16625615 | 330006124 | EKA | 100 | null | 1 | 2017-01-24 | NOT CHEMO | 330023399 | 330002908 | 330006124 |
| 16625616 | 330006124 | EE813 | 1.2 | X729 | 1 | 2017-01-25 | DAUNORUBICIN | 330023399 | 330002908 | 330006124 |
| 16625617 | 330006128 | EGT | 125 | X721 | 2 | 2014-10-31 | NOT CHEMO | 330024216 | 330002911 | 330006128 |
| 16625618 | 330006129 | ECL02 | 20 | X723 | 1 | 2018-02-20 | NOT CHEMO | 330024216 | 330002911 | 330006129 |
| 16625619 | 330006129 | ED301 | 2320 | null | 1 | 2018-02-20 | CYTARABINE | 330024216 | 330002911 | 330006129 |
| 16625620 | 330006129 | EJR | 20 | X721 | 1 | 2018-03-20 | NOT MATCHED | 330024216 | 330002911 | 330006129 |
| 16625621 | 330006129 | ECL01 | 100 | X722 | 1 | 2018-03-21 | FLUOROURACIL | 330024216 | 330002911 | 330006129 |
| 16625622 | 330006129 | EEI00 | 1800 | X721 | 1 | 2018-04-11 | VINCRISTINE | 330024216 | 330002911 | 330006129 |
| 16625623 | 330006129 | Haqrsvarq | 160 | X724 | 1 | 2018-04-11 | TRIAL | 330024216 | 330002911 | 330006129 |
| 16625624 | 330006129 | EEI00 | 3000 | X721 | 1 | 2018-04-11 | ETOPOSIDE | 330024216 | 330002911 | 330006129 |
| 16625625 | 330006129 | ENW | 1500 | X721 | 1 | 2018-04-11 | FLUOROURACIL | 330024216 | 330002911 | 330006129 |
| 16625626 | 330006129 | EE813 | 120 | null | 1 | 2018-04-11 | DOCETAXEL | 330024216 | 330002911 | 330006129 |
| 16625627 | 330006129 | EUDJC | 4 | null | 2 | 2018-04-11 | STEROID | 330024216 | 330002911 | 330006129 |
| 16625628 | 330006129 | EW100 | null | X721 | 1 | 2018-04-11 | FLUOROURACIL | 330024216 | 330002911 | 330006129 |
| 16625629 | 330006129 | EJR | 36 | X724 | 1 | 2018-04-11 | DOXORUBICIN | 330024216 | 330002911 | 330006129 |
| 16625630 | 330006129 | EE813 | 348 | X721 | 1 | 2018-04-12 | PACLITAXEL | 330024216 | 330002911 | 330006129 |
| 16625631 | 330006129 | ETG | 4 | X729 | 1 | 2018-04-19 | MIFAMURTIDE | 330024216 | 330002911 | 330006129 |
| 16625632 | 330006129 | EGU02 | 29 | X724 | 1 | 2018-04-19 | DOXORUBICIN | 330024216 | 330002911 | 330006129 |
| 16625633 | 330006129 | EW100 | 220 | null | 1 | 2018-04-19 | PACLITAXEL | 330024216 | 330002911 | 330006129 |
| 16625634 | 330006129 | EW100 | null | X721 | 1 | 2018-04-20 | FLUOROURACIL | 330024216 | 330002911 | 330006129 |
| 16625635 | 330006129 | ES4DU | 8 | null | 2 | 2018-04-20 | NOT CHEMO | 330024216 | 330002911 | 330006129 |
| 16625636 | 330006129 | EW100 | 8 | X724 | 1 | 2018-04-20 | NOT CHEMO | 330024216 | 330002911 | 330006129 |
| 16625637 | 330006129 | Haqrsvarq | 130 | X724 | 1 | 2018-04-20 | CISPLATIN | 330024216 | 330002911 | 330006129 |
| 16625638 | 330006129 | EJU04 | 0 | null | 2 | 2018-04-20 | NOT CHEMO | 330024216 | 330002911 | 330006129 |
| 16625639 | 330006129 | EUJ01 | 330 | X721 | 1 | 2018-04-20 | CARBOPLATIN | 330024216 | 330002911 | 330006129 |
| 16625640 | 330006130 | EJC | 0 | X723 | 2 | null | NOT CHEMO | 330024216 | 330002911 | 330006130 |
| 16625641 | 330006130 | EEI00 | 50 | X721 | 1 | null | AVELUMAB | 330024216 | 330002911 | 330006130 |
| 16625642 | 330006132 | EWR01 | 10 | null | 1 | 2017-11-24 | NOT CHEMO | 330024633 | 330002913 | 330006132 |
| 16625643 | 330006136 | ETD02 | 125 | null | 2 | 2017-06-12 | NOT CHEMO | 330024781 | 330002915 | 330006136 |
| 16625644 | 330006136 | EEI00 | 1.6 | X721 | 1 | 2017-07-01 | MESNA | 330024781 | 330002915 | 330006136 |